Who
Ozan Pamir
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Niagen Bioscience; CFO, Forum Markets.
In numbers
- Trades disclosed
- 13
- Buys
- 4
- Sells
- 0
- Bought
- $87K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 26 Feb 2021
- Last trade
- 30 Jun 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 8 Jul 2026 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Code A | $12K4,255 at $2.71 | filing |
| 30 Jun 2026filed 8 Jul 2026 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Code A | $12K4,255 at $2.71 | filing |
| 19 Feb 2026filed 24 Feb 2026 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —62,131 at $0.00 | filing |
| 19 Feb 2026filed 24 Feb 2026 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —62,131 at $0.00 | filing |
| 14 Nov 2025filed 17 Nov 2025 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Bought | $30K4,464.96 at $6.81 | filing |
| 14 Nov 2025filed 17 Nov 2025 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Bought | $15K2,220.44 at $6.85 | filing |
| 12 Feb 2025filed 14 Feb 2025 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,230 at $0.00 | filing |
| 22 Nov 2024filed 25 Nov 2024 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Bought | $21K2,907.2 at $7.36 | filing |
| 21 Oct 2024filed 23 Oct 2024 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —146,544 at $0.00 | filing |
| 4 Sep 2023filed 6 Sep 2023 | FRMM Forum Marketsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 18 May 2023filed 19 May 2023 | FRMM Forum MarketsConsumer & Specialty Finance | SEC FORM 4 Bought | $5,2145,162.08 at $1.01 | filing |
| 10 Dec 2021filed 13 Dec 2021 | FRMM Forum MarketsConsumer & Specialty Finance | SEC FORM 4 Bought | $15K3,800 at $3.87 | filing |
| 26 Feb 2021filed 3 Mar 2021 | FRMM Forum Marketsoption or derivative · Consumer & Specialty Finance | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.